Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021
- PMID: 39339922
- PMCID: PMC11437486
- DOI: 10.3390/v16091446
Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021
Abstract
Hepatitis C virus (HCV) infection is among the leading causes of cirrhosis and hepatocellular carcinoma. Knowledge of its prevalence and risk factors can help to effectively fight the virus. This study was the first to investigate the seroprevalence of HCV, its genotypes, and factors associated with it among the general adult population of Armenia selected countrywide via cluster sampling. Anti-HCV antibodies were detected using third-generation immunoassay. Polymerase chain reaction and genotyping was performed among anti-HCV-positive individuals. Shortly after testing, the participants underwent a telephone survey. Logistic regression models were fitted to identify factors associated with anti-HCV antibody positivity and chronic HCV infection. The prevalence of anti-HCV antibodies among 3831 tested individuals was 2% (99% CI 1.4, 2.5), and chronic HCV infection was 0.7% (99% CI 0.4, 1.0), with genotypes 3 and 2 being the most common. The risk factors for chronic HCV infection included self-reported chronic liver disease (95% CI 1.47, 15.28), having tattoos (95% CI 1.34, 10.94), ever smoking (95% CI 1.16, 9.18), and testing positive for hepatitis B virus core antibody (95% CI 1.02, 7.17). These risk factors demonstrate that there could be room for strengthening infection control measures to prevent the transmission of HCV in Armenia.
Keywords: Armenia; general population; hepatitis C virus; risk factors; seroprevalence.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Prevalence of hepatitis B virus infection among general population of Armenia in 2021 and factors associated with it: a cross-sectional study.BMJ Open. 2024 Feb 7;14(2):e080281. doi: 10.1136/bmjopen-2023-080281. BMJ Open. 2024. PMID: 38326250 Free PMC article.
-
Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.PLoS One. 2017 Apr 13;12(4):e0175525. doi: 10.1371/journal.pone.0175525. eCollection 2017. PLoS One. 2017. PMID: 28406947 Free PMC article.
-
The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.Euro Surveill. 2019 Apr;24(14):1800369. doi: 10.2807/1560-7917.ES.2019.24.14.1800369. Euro Surveill. 2019. PMID: 30968825 Free PMC article.
-
Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study.BMC Infect Dis. 2013 Feb 1;13:60. doi: 10.1186/1471-2334-13-60. BMC Infect Dis. 2013. PMID: 23374914 Free PMC article.
-
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.Clin Infect Dis. 2017 Jun 1;64(11):1573-1581. doi: 10.1093/cid/cix202. Clin Infect Dis. 2017. PMID: 28449115 Free PMC article.
Cited by
-
Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries.BMJ Open Gastroenterol. 2025 Jan 23;12(1):e001657. doi: 10.1136/bmjgast-2024-001657. BMJ Open Gastroenterol. 2025. PMID: 39848793 Free PMC article.
References
-
- Guntipalli P., Pakala R., Kumari Gara S., Ahmed F., Bhatnagar A., Endaya Coronel M.K., Razzack A.A., Solimando A.G., Thompson A., Andrews K., et al. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastroenterol. Belg. 2021;84:637–656. doi: 10.51821/84.4.015. - DOI - PubMed
-
- Seo S., Silverberg M.J., Hurley L.B., Ready J., Saxena V., Witt D., Hare C.B., Champsi J.H., Korn D.G., Pauly M.P., et al. Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled from 1998 to 2017. Clin. Gastroenterol. Hepatol. 2020;18:511–513. doi: 10.1016/j.cgh.2019.04.035. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical